These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Reverse genetics systems as tools for the development of novel therapies against filoviruses. Hoenen T, Feldmann H. Expert Rev Anti Infect Ther; 2014 Oct; 12(10):1253-63. PubMed ID: 25169588 [Abstract] [Full Text] [Related]
14. A high throughput screen identifies benzoquinoline compounds as inhibitors of Ebola virus replication. Luthra P, Liang J, Pietzsch CA, Khadka S, Edwards MR, Wei S, De S, Posner B, Bukreyev A, Ready JM, Basler CF. Antiviral Res; 2018 Feb; 150():193-201. PubMed ID: 29294299 [Abstract] [Full Text] [Related]
15. Luciferase-Expressing Ebolaviruses as Tools for Screening of Antivirals. Hoenen T. Methods Mol Biol; 2017 Feb; 1628():189-194. PubMed ID: 28573620 [Abstract] [Full Text] [Related]
16. Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections. Swenson DL, Warfield KL, Negley DL, Schmaljohn A, Aman MJ, Bavari S. Vaccine; 2005 Apr 27; 23(23):3033-42. PubMed ID: 15811650 [Abstract] [Full Text] [Related]
20. Development of a New Reverse Genetics System for Ebola Virus. Gan T, Zhou D, Huang Y, Xiao S, Ma Z, Hu X, Tong Y, Yan H, Zhong J. mSphere; 2021 May 05; 6(3):. PubMed ID: 33952663 [Abstract] [Full Text] [Related] Page: [Next] [New Search]